Boston scientific closes acquisition of axonics, inc.

Marlborough, mass. , nov. 15, 2024 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced the close of its acquisition of axonics, inc. (nasdaq: axnx), a medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
AXNX Ratings Summary
AXNX Quant Ranking